Cyclin D1 Antikörper (Ser90) (PE)
Kurzübersicht für Cyclin D1 Antikörper (Ser90) (PE) (ABIN1958676)
Target
Alle Cyclin D1 (CCND1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Ser90
-
Spezifität
- Human CCND1 / Cyclin D1
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
KLH-conjugated synthetic non-phosphopeptide around Ser90 of human Cyclin D1.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA, IHC, WB
Usage: The applications listed above are for the unconjugated form of this antibody. The conjugated antibody has not been tested. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Haltbarkeit
- 6 months
-
-
- Cyclin D1 (CCND1)
-
Andere Bezeichnung
- CCND1 / Cyclin D1
-
Hintergrund
-
Name/Gene ID: CCND1
Synonyms: CCND1, B-cell lymphoma 1 protein, BCL-1 oncogene, B-cell CLL/lymphoma 1, BCL-1, Cyclin D1, G1/S-specific cyclin-D1, U21B31, PRAD1, BCL1, D11S287E, PRAD1 oncogene -
Gen-ID
- 595
-
Pathways
- PI3K-Akt Signalweg, Zellzyklus, Mitotic G1-G1/S Phases, ER-Nucleus Signaling
Target
-